Olema Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Olema Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Olema Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$37.6M, a 61.2% decline year-over-year.
  • Olema Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$136M, a 33.6% decline year-over-year.
  • Olema Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$105M, a 1.9% increase from 2022.
  • Olema Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$107M, a 49.7% decline from 2021.
  • Olema Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$71.5M, a 232% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$105M +$2.03M +1.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 -$107M -$35.5M -49.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 -$71.5M -$50M -232% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$21.5M -$17.2M -398% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 -$4.32M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.